C202-3913 Screening compound: 3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

C202-3913 Screening compound: 3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid
C202-3913 Screening compound: 3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C202-3913
3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C202-3913

Molecular Formula

C23H20N4O3 (C23 H20 N4 O3)

Compound Name

3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

IUPAC name

3-[(2-methylphenyl)carbamoyl]-7-[(1E)-2-phenylethenyl]-4H7H-pyrazolo[15-a]pyrimidine-5-carboxylic acid

SMILES

Cc(cccc1)c1NC(c1c(NC(C(O)=O)=CC2/C=C/c3ccccc3)n2nc1)=O

InChI

InChI=1S/C23H20N4O3/c1-15-7-5-6-10-19(15)26-22(28)18-14-24-27-17(12-11-16-8-3-2-4-9-16)13-20(23(29)30)25-21(18)27/h2-14,17,25H,1H3,(H,26,28)(H,29,30)/b12-11+/t17-/m1/s1

InChI Key

HFDMKZZTLNASFJ-FMQWLBJXSA-N

MDL Number (MFCD)

MFCD14731812

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

400.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.691

Distribution Coefficient, logD

1.389

Water Solubility, LogSw

-3.84

Polar Surface Area

75.799

Acid Dissociation Constant (pKa)

5.10

Base Dissociation Constant (pKb)

-2.81

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.70

C202-3913 in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Agro:
  • Agro
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C202-3913 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C202-3913?
Check Price and Availability of C202-3913, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C202-3913 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C202-3913
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C202-3913
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C202-3913 available by request